Please assess the completion status of the following clinical trial:

Trial Title: Collagen-thrombin Matrix Efficacy During Cardiac Surgery: a Prospective Randomized Controlled Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. patients aged 19 years or older~2. undergoing elective OPCAB surgery with multi-vessel coronary artery disease.~Exclusion Criteria:~1. patients were pregnant~2. had a known sensitivity to any components of the bovine thrombin preparations or the porcine origin materials.

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Treatment arm label- Collastat® (Type: EXPERIMENTAL): None
- Control arm label- Floseal® (Type: ACTIVE_COMPARATOR): an marketed product is Floseal

Based on this trial design, predict the completion outcome and termination type (if applicable).